Novartis
2025–2026 federal contribution records · FEC Schedule A
01
Contribution summary
Loading the financial summary…
Reading the shared contribution publication for this cycle.
2025–2026 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
Current-version rows · memo entries excluded from net amount
Last updated .
A current recipient-party breakdown has not been published. Financial totals remain available; older party percentages are not shown.
Loading 10 contributions with dates…
Loading company overview…
These immutable labels appeared in FEC filings and are grouped under Novartis.
This name also gave directly as an organization. That is the organization's own money, not its employees'.View organization$10,000 this cycle
Top 10 contributors and top 10 recipients · independent of list pagination
Explore the reported connections for Novartis. Contributor and recipient lists are available below.
Data: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Reported contributor groups, with evidence-based name-variant matching; not verified unique people · 10 per page
Showing 1–10 of 218 · largest absolute amount first
Reported name + ZIP cluster; not a verified identity merge · CINCINNATI, OH, 45202 · NOVARTIS · Healthcare & Pharmaceuticals · CEO · 2 transaction rows
Reported name + ZIP cluster; not a verified identity merge · WASHINGTON, DC, 20003 · NOVARTIS · Healthcare & Pharmaceuticals · DIRECTOR · 16 transaction rows
Reported name + ZIP cluster; not a verified identity merge · WINCHESTER, MA, 01890 · NOVARTIS · Healthcare & Pharmaceuticals · BIOLOGIST · 41 transaction rows
Reported name + ZIP cluster; not a verified identity merge · VOORHEES, NJ, 08043 · NOVARTIS · Healthcare & Pharmaceuticals · MEDICAL DIRECTOR · 2 transaction rows
Reported name + ZIP cluster; not a verified identity merge · NEW YORK, NY, 10023 · NOVARTIS · Healthcare & Pharmaceuticals · CHIEF STRATEGY & GROWTH OFFICER · 2 transaction rows
Reported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · NOVARTIS CORPORATION · Healthcare & Pharmaceuticals · CHIEF STRATEGY & GROWTH OFFICER · 1 transaction rows
Reported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · NOVARTIS CORPORATION · Healthcare & Pharmaceuticals · CHIEF LEGAL OFFICER · 1 transaction rows
Reported name + ZIP cluster; not a verified identity merge · NEW YORK, NY, 10020 · NOVARTIS CORPORATION · Healthcare & Pharmaceuticals · VP, SPECIAL PROJECTS · 1 transaction rows
Reported name + ZIP cluster; not a verified identity merge · HOUSTON, TX, 77071 · NOVARTIS · Healthcare & Pharmaceuticals · SALES · 9 transaction rows
Reported name + ZIP cluster; not a verified identity merge · BROOKLINE, MA, 02446 · NOVARTIS · Healthcare & Pharmaceuticals · PHYSICIAN · 1 transaction rows
Where the contributions went · 10 per page
Showing 1–10 of 87 · largest absolute amount first
PAC (qualified) · WASHINGTON, DC · 142 transaction rows
PAC (qualified) · CINCINNATI, OH · 2 transaction rows
House campaign committee · DETROIT, MI · TLAIB, RASHIDA · U.S. House MI 12 · 38 transaction rows
PAC (qualified) · WASHINGTON, DC · 1 transaction rows
House campaign committee · HARTFORD, CT · LARSON, JOHN B · U.S. House CT 01 · 2 transaction rows
House campaign committee · PHILADELPHIA, PA · OXMAN, DAVID · U.S. House PA 03 · 3 transaction rows
House campaign committee · BLOOMFIELD, NJ · MEJIA, ANALILIA · U.S. House NJ 11 · 10 transaction rows
Party committee (qualified) · WASHINGTON, DC · 23 transaction rows
Party committee (qualified) · WASHINGTON, DC · 24 transaction rows
PAC (qualified) · WASHINGTON, DC · 2 transaction rows
Individual transactions · 10 per page
Dates below are the FEC-reported contribution dates, not filing or import dates. These are individual contributions grouped by the reported employer field, not contributions by a company.
Smallest contribution amounts first. Select Date of contribution or Amount to reverse the order.
| Date of contribution ↕ | Amount ↑ | Reported contributor / location | Recipient / filing |
|---|---|---|---|
| 2025-03-17FEC filing ↗ | $25 | SPRANGEL, CHRISTOPHERSUDBURYMA01776DIRECTOR ITNOVARTIS | JOSH WEIL FOR SENATEC00893321General 2025 (G2025)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1890528 · amended |
| 2025-06-25FEC filing ↗ | $25 | CARTER, PEGGYAPACHE JUNCTIONAZ85119REGULATORY AFFAIRSNOVARTIS | DCCCC00000935Primary (P)* EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 06/25/2025Filing 1986436 · amended |
| 2025-05-25FEC filing ↗ | $25 | CARTER, PEGGYAPACHE JUNCTIONAZ85119REGULATORY AFFAIRSNOVARTIS | DCCCC00000935Primary (P)* EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 05/25/2025Filing 1986430 · amended |
| 2025-08-25FEC filing ↗ | $25 | CARTER, PEGGYAPACHE JUNCTIONAZ85119REGULATORY AFFAIRSNOVARTIS | DCCCC00000935Primary (P)* EARMARKED CONTRIBUTION THROUGH ACTBLUE PAC ON 08/25/2025Filing 1916089 |
| 2025-08-21FEC filing ↗ | $25 | BROOKS, LISAKANSAS CITYKS66101SALESNOVARTIS | FORWARD BLUEC00835041Primary (P)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1952403 · amended |
| 2025-08-03FEC filing ↗ | $25 | SPRANGEL, CHRISTOPHER JSUDBURYMA01776DIRECTOR, ITNOVARTIS | OJEDA FOR NCC00896357Primary 2026 (P2026)Filing 1920042 |
| 2026-04-09FEC filing ↗ | $25 | SALAZAR, CYNTHIASAGINAWTX76179GLOBAL ELT SUPPLY CHAINNOVARTIS | THOMAS MASSIE FOR CONGRESSC00509729Primary 2026 (P2026)Filing 1973399 |
| 2026-03-30FEC filing ↗ | $25 | MATERNA, JOANSUFFERNNY10901MANAGERNOVARTIS | VINDMAN FOR CONGRESSC00856955Primary 2026 (P2026)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1967050 |
| 2026-03-30FEC filing ↗ | $25 | SALAZAR, CYNTHIASAGINAWTX76179GLOBAL ELT SUPPLY CHAINNOVARTIS | THOMAS MASSIE FOR CONGRESSC00509729Primary 2026 (P2026)Filing 1963651 |
| 2025-11-26FEC filing ↗ | $25 | LONETTO, MICHAELSOMERVILLEMA02144IT MANAGERNOVARTIS | 314 ACTION FUNDC00633248Primary (P)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1929219 |
Refunds remain negative. Memo-only rows are marked and are not additional money. Rows come from the latest available contribution publication.
Open full contribution table →Industry classification summary
Novartis AG is a global pharmaceutical company verified by Forbes and official records as a major developer and manufacturer of innovative prescription medicines.
AI classification auto-approved under admin authorization
View source